GrantExec

Grants for Special district governments - Education

Explore 975 grant opportunities

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 5, 2024

Date Added

Aug 8, 2023

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease.

Education
State governments
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
$350,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 17, 2024

Date Added

Aug 1, 2023

This funding opportunity supports researchers in analyzing and integrating existing data to better understand cancer risks and outcomes, ultimately advancing cancer research and treatment strategies.

Education
State governments
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
$200,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jun 16, 2025

Date Added

Aug 1, 2023

This funding opportunity provides financial support for researchers to analyze and integrate existing data to better understand cancer risk, prevention, and treatment outcomes, particularly focusing on innovative methodologies and addressing health disparities.

Education
State governments
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
$500,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Aug 14, 2024

Date Added

Jul 31, 2023

Substance use needs to be better incorporated into interventions for the engagement and retention of sexual minority persons in prevention and care with attention to emergent interventions such as long-acting PrEP. Social determinants of health associated with HIV and problematic substance use such as homelessness and criminal justice involvement also demonstrate disproportionate impact among sexual and gender minorities and need attention. Changing self-definition of sexual minority status has implications for outreach and provider stigma and needs to be better integrated into interventions. This initiative will address these gap areas and support epidemiologic, intervention, and implementation research that incorporates attention to HIV as a syndemic including comorbidities such as STIs, HCV, and psychiatric disorder.

Education
State governments
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
$225,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Aug 14, 2024

Date Added

Jul 31, 2023

Substance use needs to be better incorporated into interventions for the engagement and retention of sexual minority persons in prevention and care with attention to emergent interventions such as long-acting PrEP. Social determinants of health associated with HIV and problematic substance use such as homelessness and criminal justice involvement also demonstrate disproportionate impact among sexual and gender minorities and need attention. Changing self-definition of sexual minority status has implications for outreach and provider stigma and needs to be better integrated into interventions. This initiative will address these gap areas and support epidemiologic, intervention, and implementation research that incorporates attention to HIV as a syndemic including comorbidities such as STIs, HCV, and psychiatric disorder.

Education
State governments
NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 4, 2025

Date Added

Jul 21, 2023

This grant provides funding to educational institutions to create programs that support and encourage undergraduate students from diverse and underrepresented backgrounds to pursue advanced degrees and careers in neuroscience research.

Education
State governments
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
$475,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 7, 2024

Date Added

Jul 20, 2023

This grant provides funding for researchers at U.S. institutions to explore innovative uses of nanotechnology in cancer research, focusing on improving targeted delivery and diagnostic capabilities for specific cancer types.

Education
State governments
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
$450,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 27, 2024

Date Added

Jul 19, 2023

This funding opportunity is designed to support research that develops and tests new ways to integrate HIV/AIDS, Hepatitis, and substance use disorder prevention and treatment services to improve health outcomes for individuals at high risk or living with these conditions in the U.S.

Education
State governments
Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 25, 2024

Date Added

Jul 19, 2023

This grant provides funding for researchers to explore how HIV and substance use disorders affect protein interactions in microglia, aiming to uncover mechanisms that could lead to new treatments for these interconnected conditions.

Education
State governments
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 15, 2024

Date Added

Jul 19, 2023

The "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services" grant aims to fund research for developing and testing new care models that effectively combine HIV, addiction, and primary care services to improve health outcomes for individuals at high risk for or living with HIV, Hepatitis, and substance use disorders in the US.

Education
State governments
Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
$275,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 1, 2024

Date Added

Jul 5, 2023

This funding opportunity provides financial support for researchers to quickly investigate the immediate health impacts of unexpected environmental events, such as disasters or policy changes, by collecting critical data in partnership with affected communities.

Education
State governments
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 14, 2024

Date Added

Jun 16, 2023

This grant provides funding for researchers to develop and validate innovative tools that improve the analysis of brain circuits and cellular interactions, with a focus on targeting specific cell types and circuits across various species.

Education
State governments
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 11, 2025

Date Added

Jun 15, 2023

This funding opportunity supports doctoral candidates conducting research on substance use and substance use disorders, helping them complete their dissertation projects while fostering new talent in the field.

Education
State governments
ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
$220,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

May 25, 2025

Date Added

Jun 6, 2023

This funding opportunity provides financial support for research organizations to establish expert panels that will evaluate and curate genomic variants linked to important diseases, enhancing clinical understanding and treatment options.

Education
State governments
Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 17, 2025

Date Added

Jun 5, 2023

This funding opportunity supports innovative research projects that aim to improve health outcomes through the equitable use of genomics, particularly for underrepresented populations in the U.S.

Education
State governments
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal
Rolling

Application Deadline

Jul 8, 2026

Date Added

May 26, 2023

This grant provides access to advanced genetic and genomic analysis services for research projects focused on understanding genetic factors in human health and disease, without offering direct funding.

Health
State governments
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
$75,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 26, 2026

Date Added

May 17, 2023

This funding opportunity provides financial support for the creation of significant scholarly works in biomedicine and health, aimed at researchers, public health officials, and scholars in the U.S. who are addressing critical gaps in these fields.

Education
State governments
Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
$200,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 22, 2025

Date Added

May 10, 2023

This funding opportunity supports research projects aimed at reducing stigma related to HIV/AIDS in low- and middle-income countries, with a focus on improving health outcomes for affected populations.

Education
State governments
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
$150,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 8, 2025

Date Added

May 10, 2023

This funding opportunity supports research initiatives focused on non-communicable diseases related to HIV at institutions in low- and middle-income countries, encouraging innovative projects and collaborations to improve health outcomes for people living with HIV.

Education
State governments
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
$10,000,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 7, 2024

Date Added

May 8, 2023

Reissue of RFA-MH-22-115 to comply with DMSP policy. The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis and manipulation of complex circuits and provide insights into cellular interactions that underlie brain function. Critical advances in the treatment of brain disorders in human populations are hindered by our lack of ability to monitor and manipulate circuitry in safe, minimally-invasive ways. Clinical intervention with novel cell and circuit specific tools will require extensive focused research designed to remove barriers to delivery of gene therapies. In addition to identification and removal of barriers, the need to specifically target dysfunctional circuitry poses additional challenges. Neuroscience has experienced an impressive influx of exciting new research tools in the past decade, especially since the launch of the BRAIN Initiative. However, the majority of these cutting edge tools have been developed for use in model organisms, primarily rodents, fish and flies. These cutting edge tools, such as viral delivery of genetic constructs, are increasingly adaptable to large brains and more importantly are emerging as potential human therapeutic strategies for brain disorders. A pressing need to develop tools for use in large brains, more directly relevant to the human brain is the focus of this initiative. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application.

Education
State governments